This site is intended only for the use of UK Healthcare Professionals

HMO Hub

Highlight of the month

CINNAMON Study Video

CINNAMON Study Video

Breastmilk remains the nutritional gold standard for all infants, including those with Cow's Milk Protein Allergy (CMPA). Building on decades of pioneering research, Nestlé Health Science continues to innovate by bringing structurally identical Human Milk Oligosaccharides (HMOs) to hypoallergenic formula.This video explores findings from the CINNAMON Study, a randomized, controlled, double-blind clinical trial evaluating a hypoallergenic formula enhanced with two HMOs. The study demonstrated effective relief of CMPA symptoms, fewer respiratory infections, and a gut microbiota profile closer to that of breastfed infants.

See more